tert-butyl (2S,3S)-3-hydroxy-1-phenylheptan-2-ylcarbamate | 157394-65-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: tert-butyl (2S,3S)-3-hydroxy-1-phenylheptan-2-ylcarbamate
• 英文别名: tert-butyl (1S,2S)-1-benzyl-2-hydroxyhexylcarbamate；tert-butyl N-[(2S,3S)-3-hydroxy-1-phenylheptan-2-yl]carbamate
• CAS: 157394-65-5
• 化学式: C₁₈H₂₉NO₃
• 分子量: 307.433
• InChiKey: CTCFODBCPLDNNJ-HOTGVXAUSA-N

物化性质

• 沸点：
  453.7±38.0 °C(predicted)
• 密度：
  1.031±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  22
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.61
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl (2S,3S)-3-hydroxy-1-phenylheptan-2-ylcarbamate 在 三(2-氯乙基)胺 、 三苯基膦 、 偶氮二甲酸二乙酯 作用下， 生成 tert-butyl (1S,2S)-2-azido-1-benzylhexylcarbamate
  参考文献：
  名称：

  Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in a N-terminal 10s-loop down conformation

  摘要：

  A series of low-molecular weight 2,6-diamino-isonicotinamide BACE-I inhibitors containing an amine transition-state isostere were synthesized and shown to be highly potent in both enzymatic and cell-based assays. These inhibitors contain a trans-S,S-methyl cyclopropane P-3 which bind BACE-1 in a 10s-loop down conformation giving rise to highly potent compounds with favorable molecular weight and moderate to high susceptibility to P-glycoprotein (P-gp) efflux. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.12.051
• 作为产物：
  描述：

  tert-butyl (2S,3S,Z)-3-hydroxy-1-phenylhepta-4,6-dien-2-ylcarbamate 在 Crabtree's catalyst 、 氢气 作用下， 以 二氯甲烷 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 反应 48.0h， 以70%的产率得到tert-butyl (2S,3S)-3-hydroxy-1-phenylheptan-2-ylcarbamate
  参考文献：
  名称：

  乙炔与 α-手性醛氢化偶联中的催化剂导向非对映选择性：所有八种 L-己糖的正式合成。

  摘要：

  使用由 (S)-MeO-BIPHEP 和 (R)-MeO-BIPHEP 连接的对映体铑催化剂将乙炔氢化偶联至 α-手性醛 1a-4a 提供羰基-(Z)-丁二烯基化的非对映体产物 1b-4b 和 1c -4c，分别具有良好到优异水平的催化剂定向非对映面选择性。非对映体 L-甘油醛丙酮化物加合物 1b 和 1c 被转化为四种异构烯酸酯 6b、8b、6c 和 8c，代表所有八种 L-己糖的正式合成。

  DOI：

  10.1021/ol8018874

文献信息

• Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
  申请人：Barrow C. James

  公开号：US20070142634A1

  公开（公告）日：2007-06-21

  The present invention is directed to phenylamide and pyridylamide derivative compounds of which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及苯胺和吡啶胺衍生物化合物，这些化合物是β-分泌酶的抑制剂，并且在治疗涉及β-分泌酶的疾病，如阿尔茨海默病中有用。该发明还涉及包含这些化合物的药物组合物，以及在治疗涉及β-分泌酶的这类疾病中使用这些化合物和组合物。
• Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease
  申请人：Merck & Co., Inc.

  公开号：US07550481B2

  公开（公告）日：2009-06-23

  The present invention is directed to phenylamide and pyridylamide derivative compounds of which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及苯基酰胺和吡啶基酰胺衍生物化合物，其是β-分泌酶酶的抑制剂，可用于治疗β-分泌酶酶涉及的疾病，如阿尔茨海默病。本发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在治疗β-分泌酶酶涉及的疾病中的使用。
• A simple method for chelation controlled additions to α-amino aldehydes
  作者：Manfred T. Reetz、Karin Rölfing、Nils Griebenow

  DOI：10.1016/s0040-4039(00)73024-3

  日期：1994.3

  BOC- and Cbz-protected alpha-amino aldehydes derived from amino acids undergo stereoselective addition reactions with alkyl cuprates and manganese reagents, the chelation-controlled adducts being the major diastereomers (generally ds > 90%). Undesired racemization is not observed (ee > 99%).
• Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind β-secretase in a N-terminal 10s-loop down conformation
  作者：Shaun R. Stauffer、Matthew G. Stanton、Alison R. Gregro、Melissa A. Steinbeiser、Jennifer R. Shaffer、Philippe G. Nantermet、James C. Barrow、Kenneth E. Rittle、Dennis Collusi、Amy S. Espeseth、Ming-Tain Lai、Beth L. Pietrak、M. Katharine Holloway、Georgia B. McGaughey、Sanjeev K. Munshi、Jerome H. Hochman、Adam J. Simon、Harold G. Selnick、Samuel L. Graham、Joseph P. Vacca

  DOI：10.1016/j.bmcl.2006.12.051

  日期：2007.3

  A series of low-molecular weight 2,6-diamino-isonicotinamide BACE-I inhibitors containing an amine transition-state isostere were synthesized and shown to be highly potent in both enzymatic and cell-based assays. These inhibitors contain a trans-S,S-methyl cyclopropane P-3 which bind BACE-1 in a 10s-loop down conformation giving rise to highly potent compounds with favorable molecular weight and moderate to high susceptibility to P-glycoprotein (P-gp) efflux. (c) 2007 Elsevier Ltd. All rights reserved.
• Catalyst-Directed Diastereoselectivity in Hydrogenative Couplings of Acetylene to α-Chiral Aldehydes: Formal Synthesis of All Eight <scp>l</scp>-Hexoses
  作者：Soo Bong Han、Jong Rock Kong、Michael J. Krische

  DOI：10.1021/ol8018874

  日期：2008.9.18

  directed diastereofacial selectivity. Diastereomeric L-glyceraldehyde acetonide adducts 1b and 1c were converted to the four isomeric enoates 6b, 8b, 6c, and 8c, representing a formal synthesis of all eight L-hexoses.

  使用由 (S)-MeO-BIPHEP 和 (R)-MeO-BIPHEP 连接的对映体铑催化剂将乙炔氢化偶联至 α-手性醛 1a-4a 提供羰基-(Z)-丁二烯基化的非对映体产物 1b-4b 和 1c -4c，分别具有良好到优异水平的催化剂定向非对映面选择性。非对映体 L-甘油醛丙酮化物加合物 1b 和 1c 被转化为四种异构烯酸酯 6b、8b、6c 和 8c，代表所有八种 L-己糖的正式合成。